CanaFarma Hemp Products Corp.
CNFHF
$0.0001
$0.000.00%
| Weiss Ratings | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 40.86 | |||
| Price History | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | -90.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 20, 2024 | |||
| 52-Week High Price (Date) | Oct 15, 2024 | |||
| Valuation | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 21.89K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -36.82% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -0.04 | |||
| Price/Book (Q) | -0.03 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 201.57M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 214 704 7942 | |||
| Address | 2080 - 777 Hornby Street Vancouver, BC V6Z 1S4 | |||
| Website | -- | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2,760.45% | |||
| Profit Margin | 1,928.37% | |||
| Management Effectiveness | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -183.08% | |||
| Return on Equity | -- | |||
| Income Statement | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -514.10K | |||
| Total Revenue (TTM) | -514.10K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -5.27M | |||
| EBITDA (TTM) | -14.06M | |||
| EBIT (TTM) | -14.19M | |||
| Net Income (TTM) | -9.91M | |||
| Net Income Avl. to Common (TTM) | -9.91M | |||
| Total Revenue Growth (Q YOY) | 511.63% | |||
| Earnings Growth (Q YOY) | 92.80% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | 94.15% | |||
| Balance Sheet | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 738.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -636.90K | |||
| Current Ratio (Q) | 0.332 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 1.83M | |||
| Total Current Liabilities (Q) | 2.22M | |||
| Total Debt (Q) | 244.30K | |||
| Total Liabilities (Q) | 2.47M | |||
| Total Common Equity (Q) | -636.90K | |||
| Cash Flow | CNFHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 844.60K | |||
| Cash from Financing (TTM) | 244.30K | |||
| Net Change in Cash (TTM) | -1.22M | |||
| Levered Free Cash Flow (TTM) | 104.80K | |||
| Cash from Operations (TTM) | -2.33M | |||
